Form 8-K - Current report:
SEC Accession No. 0001570562-21-000139
Filing Date
2021-05-12
Accepted
2021-05-12 16:09:35
Documents
16
Period of Report
2021-05-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20210512.htm   iXBRL 8-K 34112
2 EX-99.1 q12021eolsex991.htm EX-99.1 120323
8 evoluslogohorizontal1.jpg GRAPHIC 270362
  Complete submission text file 0001570562-21-000139.txt   665103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210512.xsd EX-101.SCH 2430
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20210512_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20210512_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210512_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210512_pre.xml EX-101.PRE 13195
9 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210512_htm.xml XML 11034
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 21915148
SIC: 2834 Pharmaceutical Preparations